Citations

Showing 10 of 108104 citations.

A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. cooperative group trials: Comparing the outcomes of elderly to younger patients (pts).
Stinchcombe, Tom, Zhang, Ying J., Schiller, Joan H. , Curran, Walter J. , Movsas, Benjamin , Clamon, Gerald H., Blumenschein, George R. , Ready, Neal , Akerley, Wallace , Cohen, Harvey Jay, Wang, Xiaofei F., Stinchcombe, Thomas E. , Vokes, Everett E. , Bradley, Jeffrey D. , Schild, Steven E. , Govindan, Ramaswamy , Socinski, Mark A. , Pang, Herbert

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8508-8508

10.1200/jco.2016.34.15_suppl.8508 Get It

Type 1 monoclonal cryoglobulinemia: Clinical presentation and outcomes.
Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Zeldenrust, Steven R., Lust, John A., Kyle, Robert A. , Kumar, Shaji , Sidana, Surbhi , Rajkumar, S. Vincent , Dispenzieri, Angela , Gertz, Morie A. , Buadi, Francis K. , Dingli, David , Gonsalves, Wilson I. , Leung, Nelson

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8062-8062

10.1200/jco.2016.34.15_suppl.8062 Get It

Importance of pharmacovigilance in the era of small molecules: Role of pharmacist consultation with ixazomib (IXA) in multiple myeloma (MM).
Finnes, Heidi D. , Kumar, Shaji , LaPlant, Betsy, Lacy, Martha Q. , Merten, Julianna A., Bartoo, Gabriel , Kapoor, Prashant , Gertz, Morie A. , Buadi, Francis K. , Dispenzieri, Angela , McCullough, Kristen , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8058-8058

10.1200/jco.2016.34.15_suppl.8058 Get It

Changes in serum alkaline phosphatase levels to predict response to ixazomib-based therapy in patients with newly diagnosed multiple myeloma.
Tandon, Nidhi , Lacy, Martha Q. , Kapoor, Prashant , Hwa, Yi L. , Fonder, Amie , Hobbs, Miriam, Hayman, Suzanne R. , Zeldenrust, Steven R., Lust, John A., Kumar, Shaji , Buadi, Francis K. , Leung, Nelson , Go, Ronald S. , Dingli, David , Gertz, Morie A. , Lin, Yi , Dispenzieri, Angela , Drake, Matthew T. , Gonsalves, Wilson I. , Rajkumar, S. Vincent

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8053-8053

10.1200/jco.2016.34.15_suppl.8053 Get It

Prevalence and survival of smoldering multiple myeloma in the US: Analysis using a national dataset.
Bartley, Adam C. , Ashrani, Aneel A. , Hashmi, Shahrukh K. , Kapoor, Prashant , Kyle, Robert A. , Ravindran, Aishwarya , Gonsalves, Wilson I. , Marshall, Ariela L. , Siddiqui, Mustaqeem , Dispenzieri, Angela , Rajkumar, S. Vincent , Go, Ronald S.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8035-8035

10.1200/jco.2016.34.15_suppl.8035 Get It

Economic evaluation of carfilzomib + lenalidomide + dexamethasone (KRd) vs. lenalidomide + dexamethasone (Rd) in relapsed or refractory multiple myeloma (R/RMM).
Benedict, Ágnes , Panjabi, Sumeet , Houisse, Ivan, Campioni, Marco, Giannopoulou, Andromachi, Aggarwal, Sanjay , Jakubowiak, Andrzej , Fonseca, Rafaël

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8021-8021

10.1200/jco.2016.34.15_suppl.8021 Get It

Efficacy and safety of ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM) by cytogenetic risk status in the global phase III Tourmaline-MM1 study.
Richardson, Paul G. , Palumbo, Antonio , Viterbo, Luísa, Nagler, Arnon , Yehuda, Dina Ben , Pour, Luděk, Langer, Christian , Pluta, Andrzej, Berg, Deborah, Velde, Helgi van de , Esseltine, Dixie-Lee, Bacco, Alessandra Di , Richardson, Paul Gerard Guy , Avet‐Loiseau, Hervé , Ganly, Peter S. , Miguel, Jesús F. San , Rajkumar, S. Vincent , Bahlis, Nizar Jacques , Masszi, Tamás , Lin, Jianchang , Esseltine, Dixie‐Lee, Moreau, Philippe

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8018-8018

10.1200/jco.2016.34.15_suppl.8018 Get It

Immunoparesis in newly diagnosed AL amyloidosis as a marker for response and survival.
Kumar, Shaji , Lacy, Martha Q. , Zeldenrust, Steven R., Hayman, Suzanne R. , Kourelis, Taxiarchis , Lust, John A., Kapoor, Prashant , Kyle, Robert A. , Muchtar, Eli , Dispenzieri, Angela , Buadi, Francis K. , Leung, Nelson , Gonsalves, Wilson I. , Chakraborty, Rajshekhar , Dingli, David , Lin, Yi , Go, Ronald S. , Rajkumar, S. Vincent , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8016-8016

10.1200/jco.2016.34.15_suppl.8016 Get It

Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression.
Timm, Michael, Morice, William G. , Lacy, Martha Q. , Kapoor, Prashant , Hayman, Suzanne R. , Lust, John A., Zeldenrust, Steven R., Kourelis, Taxiarchis , Hwa, Yi L. , Kyle, Robert A. , Kumar, Shaji , Gonsalves, Wilson I. , Rajkumar, S. Vincent , Morice, William George , Dispenzieri, Angela , Buadi, Francis K. , Dingli, David , Go, Ronald S. , Leung, Nelson , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8015-8015

10.1200/jco.2016.34.15_suppl.8015 Get It